Rachel Sharpe
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 2
- Oncology top 5%
- Cancer Cells and Metastasis 2
- Molecular Biology top 10%
- Fibroblast Growth Factor Research 5
- Genomics and Chromatin Dynamics 2
- Cell Biology top 10%
-
- Genomic variations and chromosomal abnormalities 2
-
- Interprofessional Education and Collaboration 2
- Geriatric Care and Nursing Homes 2
-
- Palliative Care and End-of-Life Issues 1
- Co-authors
- Nicholas C. TurnerRachael NatrajanAlex PearsonAlan AshworthJorge S. Reis‐FilhoAlan MackayFelipe C. GeyerMaryou Lambros
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Rachel Sharpe
17 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 420
- Oncology 603
- Molecular Biology 948
- Pulmonary and Respiratory Medicine 253
- Cell Biology 116
Countries citing papers authored by Rachel Sharpe
This map shows the geographic impact of Rachel Sharpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Sharpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Sharpe more than expected).
Fields of papers citing papers by Rachel Sharpe
This network shows the impact of papers produced by Rachel Sharpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Sharpe. The network helps show where Rachel Sharpe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel Sharpe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 37 | |
| 2 | 2019 | 1 | |
| 3 | 2018 | 36 | |
| 4 | 2018 | 1 | |
| 5 | 2017 | 15 | |
| 6 | 2016 | 18 | |
| 7 | Dementia Education in Hertfordshire and Bedfordshire: An organisational audit commissioned by Health Education East of England | 2014 | 3 |
| 8 | 2013 | 28 | |
| 9 | 2013 | 22 | |
| 10 | 2013 | 142 | |
| 11 | 2012 | 252 | |
| 12 | 2011 | 144 | |
| 13 | FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancerbreakdown → | 2010 | 544 |
| 14 | 2010 | 322 | |
| 15 | 2010 | 15 | |
| 16 | 2010 | 1 | |
| 17 | 2009 | 1 |
About Rachel Sharpe
Rachel Sharpe is a scholar working on Neuropsychology and Physiological Psychology, Classics and Sensory Systems, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (5 papers), Genomic variations and chromosomal abnormalities (2 papers), Cancer Cells and Metastasis (2 papers), Interprofessional Education and Collaboration (2 papers), Geriatric Care and Nursing Homes (2 papers), Cancer Genomics and Diagnostics (2 papers), Genomics and Chromatin Dynamics (2 papers) and Palliative Care and End-of-Life Issues (1 paper). The work is most often cited by research in Cancer Research (420 citations), Oncology (603 citations) and Molecular Biology (948 citations). Rachel Sharpe has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Nicholas C. Turner, Rachael Natrajan, Alex Pearson, Alan Ashworth, Jorge S. Reis‐Filho, Alan Mackay, Felipe C. Geyer, Maryou Lambros, Caterina Marchiò and Elizabeth Iorns.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.